Product image of Zemplar (Paricalcitol) supplied by GNH India

Zemplar

Active Ingredient:
Paricalcitol
Origin:
EU

Zemplar (Paricalcitol)

Paricalcitol (Zemplar) is an intravenous vitamin D analog prescribed to manage secondary hyperparathyroidism in chronic kidney disease. It helps regulate calcium and phosphorus levels. This EU-manufactured treatment supports bone health in dialysis patients.

Manufacturer / TM Owner

Abbvie D.O.O. (Croatia)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Paricalcitol is used to treat secondary hyperparathyroidism in adults and pediatric patients 5 years and older with chronic kidney disease. It works by reducing elevated parathyroid hormone levels that can lead to bone disorders. Patients undergoing dialysis often require this medication to maintain mineral balance. The intravenous form is administered by healthcare professionals during treatment sessions.

Side Effects

  • Paricalcitol helps normalize calcium and phosphorus levels in the bloodstream, which may improve symptoms related to bone discomfort or weakness. Some patients report reduced itching or muscle cramps as their mineral levels stabilize. Regular monitoring is typically required to assess response and adjust dosing as needed.

Precautions & Warnings

  • Paricalcitol should only be used under medical supervision due to the risk of elevated calcium levels. Patients with a history of seizures or heart conditions should inform their healthcare provider before starting treatment. Blood tests are commonly performed to check calcium, phosphorus, and parathyroid hormone levels during therapy.

Avoid Interactions

  • Certain medications, including strong CYP3A inhibitors like ketoconazole, may increase paricalcitol levels in the blood. Patients should discuss all prescription drugs, over-the-counter supplements, and herbal products with their doctor. Grapefruit products may also interact with paricalcitol and should be avoided unless approved by a healthcare professional.

Frequently Asked Questions

Paricalcitol is prescribed to treat secondary hyperparathyroidism in patients with chronic kidney disease, particularly those on dialysis.

Paricalcitol is given as an intravenous injection by a healthcare provider during dialysis sessions or clinic visits.

Always consult your doctor before combining paricalcitol with other drugs, as some may interact and affect its effectiveness or safety.

Common effects may include nausea, vomiting, or mild dizziness; however, individual responses vary and should be discussed with a healthcare provider.

Paricalcitol is approved for children aged 5 years and older with chronic kidney disease and secondary hyperparathyroidism under medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Paricalcitol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT